Research location
Tipton
Pennsylvania, United States
Advertisement
Research activity in Tipton
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 56 trials and 56 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Tipton
56 linked trials · page 2 of 2A Study of GK Activator (2) in Patients With Type 2 Diabetes MellitusNCT00266240 · 2005-11-01 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesNCT00240253 · 2005-10-01 · 1 site observation
COMPLETED
Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesNCT00106808 · 2005-08-01 · 1 site observation
COMPLETED
Extension Study for 2993-112NCT01789957 · 2002-09-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminNCT00039013 · 2002-03-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaNCT00039026 · 2002-02-01 · 1 site observation
COMPLETED
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.